根据最新的财务报表(Form-10K),Apyx Medical Inc 的总资产为 $0,净亏损为 $0
APYX 的关键财务比率是什么?
Apyx Medical Inc 的流动比率是 0,净利 margin 为 0,每股销售为 $0。
Apyx Medical Inc 的收入按细分市场或地理位置如何划分?
Apyx Medical Inc 最大收入来源是 Surgical Aesthetics,在最近的收益报告中收入为 45,332,000。就地区而言, United States 是 Apyx Medical Inc 的主要市场,收入为 38,801,000。
Apyx Medical Inc 是否盈利?
否,根据最新的财务报表,Apyx Medical Inc 的净亏损为 $0
Apyx Medical Inc 有负债吗?
否,Apyx Medical Inc 的负债为 0
Apyx Medical Inc 的流通股有多少?
Apyx Medical Inc 的总流通股为 0
关键数据
前收盘价
$4.11
开盘价
$4.07
当日区间
$3.96 - $4.11
52周范围
-
交易量
160.2K
平均成交量
--
股息收益率
--
每股收益(TTM)
--
市值
--
什么是 APYX?
Apyx Medical Corp. operates as an energy-based medical technology company. The company is headquartered in Clearwater, Florida and currently employs 205 full-time employees. Its segments include Advanced Energy and Original Equipment Manufacturer (OEM). The Advanced Energy segment’s product portfolio consists of its Helium Plasma Technology that is marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma in the hospital surgical market. The company focuses on the cosmetic surgery market, where Renuvion offers plastic surgeons, facial plastic surgeons and cosmetic physicians the ability to provide controlled heat to the tissue to achieve their desired results. These product lines consist of a multifunction generator, a handpiece and a supply of helium gas. Through OEM agreements, the OEM segment, designs, develops and manufactures electrosurgical equipment and medical devices by producing generators, medical devices and related accessories for medical device manufacturers as well as start-up businesses in need of its energy-based designs.